01 2Carafate
02 2Carafate/Sulcrate
03 1Carafate?/Sulcrate?
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2017 Revenue in Millions : 239
2016 Revenue in Millions : 231
Growth (%) : 3
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 221
2017 Revenue in Millions : 239
Growth (%) : -8%
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2016 Revenue in Millions : 231
2015 Revenue in Millions : 213
Growth (%) : 8
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2019 Revenue in Millions : 216
2018 Revenue in Millions : 221
Growth (%) : -2
Main Therapeutic Indication : Gastrointestinal disorders
Currency : USD
2014 Revenue in Millions :
2013 Revenue in Millions :
Growth (%) :
LOOKING FOR A SUPPLIER?